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Abstract
Background: The risk for occupational exposure to HIV has been well characterized in the developed world, but limited
information is available about this transmission risk in resource-constrained settings facing the largest burden of HIV
infection. In addition, the feasibility and utilization of post-exposure prophylaxis (PEP) programs in these settings are
unclear. Therefore, we examined the rate and characteristics of occupational exposure to HIV and the utilization of PEP
among health care workers (HCW) in a large, urban government teaching hospital in Pune, India.
Methods: Demographic and clinical data on occupational exposures and their management were prospectively collected
from January 2003–December 2005. US Centers for Diseases Control guidelines were utilized to define risk exposures,
for which PEP was recommended. Incidence rates of reported exposures and trends in PEP utilization were examined
using logistic regression.
Results: Of 1955 HCW, 557 exposures were reported by 484 HCW with an incidence of 9.5 exposures per 100
person-years (PY). Housestaff, particularly interns, reported the greatest number of exposures with an annual incidence
of 47.0 per 100 PY. Personal protective equipment (PPE) was used in only 55.1% of these exposures. The incidence of
high-risk exposures was 6.8/100 PY (n = 339); 49.1% occurred during a procedure or disposing of equipment and 265
(80.0%) received a stat dose of PEP. After excluding cases in which the source tested HIV negative, 48.4% of high-risk
cases began an extended PEP regimen, of whom only 49.5% completed it. There were no HIV or Hepatitis B
seroconversions identified. Extended PEP was continued unnecessarily in 7 (35%) of 20 cases who were confirmed to be
HIV-negative. Over time, there was a significant reduction in proportion of percutaneous exposures and high-risk
exposures (p < 0.01) and an increase in PEP utilization for high risk exposures (44% in 2003 to 100% in 2005, p = 0.002).
Conclusion: Housestaff are a vulnerable population at high risk for bloodborne exposures in teaching hospital settings
in India. With implementation of a hospital-wide PEP program, there was an encouraging decrease of high-risk exposures
over time and appropriate use of PEP. However, overall use of PPE was low, suggesting further measures are needed to
prevent occupational exposures in India.
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Background
Occupational exposure to blood or other body fluids in
healthcare settings constitutes a small but significant risk
of transmission of HIV and other blood-borne pathogens
[1,2]. In addition, such exposures can cause tremendous
anxiety, fear and stress among healthcare workers (HCW)
that can have a negative impact not only on the HCW, but
also their families and colleagues [3]. The World Health
Organization estimates that 3 million percutaneous expo-
sures occur annually among 35 million HCW globally,
with over 90% occurring in resource-contrained countries
[4]. As a consequence of these exposures, an estimated
66,000 hepatitis B, 16,000 hepatitis C, and up to 1000
HIV infections occur each year.
These infections acquired through the occupational route
are largely preventable through strict infection control,
universal precautions, use of safe devices, proper waste
disposal, immunization against hepatitis B virus, and
prompt management of exposures including the use of
post-exposure prophylaxis (PEP) for HIV (estimated to
reduce HIV seroconversion by 81%) [5]. The use of these
strategies are now the standard of care in most high-
income nations and have reduced the risk of HIV and hep-
atitis transmission among HCW. In resource-constrained
settings where the largest burden of HIV and hepatitis
exist, however, there is limited surveillance and data
regarding health care-related occupational exposures and
the use of PEP. Furthermore, a lack of personal protective
equipment (PPE), availability of safe devices, proper dis-
posal of sharps and waste, and a high demand for injec-
tions place HCW in these settings at high risk for
occupational exposures and infection [2].
India has a population of approximately 1 billion and an
estimated HIV adult seroprevalence of 0.3% (2.5 million
persons), a Hepatitis B surface antigen (HBsAg) positivity
of 1–8% and a <1% prevalence of Hepatitis C in the gen-
eral population currently [6-11]. Data specific to hospital-
based prevalence of HIV, Hepatitis B and Hepatitis C are
limited and vary by region in India. Prevalence for HIV is
higher in hospitalized patients, than that in the general
population. Limited data suggest that HCW in India may
have a high frequency of occupational exposures to blood
[12], are not adequately implementing universal precau-
tions [13], are not aware of the true risk of occupational
HIV transmission, and have little knowledge of PEP [14]
compared to HCW in many Western settings.
To expand the understanding of this issue in resource-
constrained settings, like India, we evaluated the epidemi-
ology of occupational exposures and the utilization of a
newly established PEP program among HCW in a large,
urban government teaching hospital in Pune, where HIV
antenatal prevalence was approximately 3.5%.
Methods
Setting
The Byramji Jeejeebhoy Medical College (BJMC) and Sas-
soon Hospital have an ongoing NIH-funded clinical trial
collaboration with Johns Hopkins University School of
Medicine to prevent maternal-to-infant HIV transmission.
As part of this collaboration, a hospital-wide PEP program
based on U.S. Centers for Disease Control and Prevention
(CDC) guidelines for the management of occupational
exposures to blood-borne pathogens was initiated in
August 2002 [1]. This study was approved by the Johns
Hopkins and the BJMC IRB and Ethics Committee, respec-
tively.
Approximately 1,955 HCW work at Sassoon Hospital,
BJMC. Within six months of the program's initiation,
occupational safety training was begun for all incoming
interns through the Department of Medicine and for all
nurses through the ongoing NIH-sponsored trial.
At all sites gloves and masks were generally available in
wards and clinics, while procedure rooms also stocked
gowns. PPE, in part, was supplied by the clinical trial to
ensure these were available to HCW involved with the
trial when government supplies were unavailable. Posters
explaining the PEP protocol with contact information in
event of exposure were displayed throughout the hospital.
Exposure management
An exposed HCW reported to the trial's medical research
officer or to a designated Department of Medicine physi-
cian. This physician administered a detailed question-
naire regarding the timing and setting of exposure,
assessed the severity of exposure and investigated source
patient status. Using the then available 2001 CDC occu-
pational exposures management guidelines, an exposure
was defined as high-risk and warranted a stat dose of PEP
if the exposure was percutaneous or mucocutaneous and
1) the source was known to be HIV-infected, 2) the source
was felt to be at high risk for HIV infection, or 3) the
source was unknown (e.g., needlestick exposure while
removing a trash bag) or the source's risk factors for HIV
infection were unknown [1].
The last criterion for high-risk exposure was formulated
using CDC's recommendations to administer PEP for
source of unknown HIV status or an unknown source,
regardless of the severity or type of exposure, "in settings
where exposure to HIV-infected persons is likely." The
HIV prevalence among antenatal attendees at the study
site is approximately 3.5% and is assumed to be higher in
the hospitalized population. Given these prevalence rates,
our clinicians felt that unless a source was specifically
judged to be low risk for HIV, all cases with an unknown
source or unknown source risk factors for HIV would gen-BMC Infectious Diseases 2008, 8:142 http://www.biomedcentral.com/1471-2334/8/142
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erally merit a stat dose PEP. However, case-by-case deci-
sions were made by clinicians who interviewed HCW.
Initial stat PEP dose was: (1) zidovudine and lamuvidine,
or (2) zidovudine, lamuvidine and indinavir (both pro-
vided for free by NIH-sponsored clinical trial). Source
consent for rapid HIV testing was performed during office
hours at the hospital's voluntary counseling and testing
center laboratory at a cost of 10 Indian rupees (INR)
($0.25 USD). During off-hours, the Department of Micro-
biology resident on emergency call or a trial laboratory
technician performed the test. HBsAg testing was per-
formed at a cost, with both HCW and source patients each
incurring costs of INR 80–120 ($2–3 USD) per test. Each
exposed HCW was offered free baseline as well as follow-
up laboratory studies at the hospital's laboratory (com-
plete blood count, liver transaminases, serum creatinine
and HIV test). Hepatitis B testing was advised for non-
immunized individuals and was paid for by the HCW.
Standard Hepatitis B management was provided if case
deemed to be at high risk exposure (immune globulin if
not vaccinated or HCW status unknown and Hepatitis B
vaccination if not previously vaccinated). Hepatitis C sta-
tus was not assessed in source or HCW. The clinical trial
pharmacist or laboratory technician dispensed stat HIV
PEP doses. Prescriptions for extended PEP (total 28-day
course) were refilled every seven days through the clinical
trial pharmacy if the treating clinician recommended it.
Extended PEP regimens were either zidovudine and lamu-
vidine, or zidovudine, lamuvidine and indinavir.
Data Collection
Beginning in January 2003, demographic and clinical data
were collected using a standardized questionnaire on all
reported exposures. Data collected included age, sex,
occupation, department and Hepatitis B vaccination sta-
tus of HCW. HCW were asked about the type of exposure
(needle, laceration or splash), use of PPE and activity dur-
ing exposure. The treating physician then categorized the
exposure as more or less severe according to CDC guide-
lines [1].
The exposed HCW also facilitated the assessment of
source, reporting on source location and HIV status if
known. Whenever possible, the treating physician
attempted to directly evaluate the source's risk factors for
HIV and categorized them as high or low risk for HIV
infection. When a direct assessment was not possible, the
physician relied on the reporting HCW if he/she was a
physician or used the severity of exposure as the only cri-
terion for subsequent interventions. For HCW who were
prescribed extended PEP regimens, pharmacy records of
their prescriptions were used to track the type of regimen
prescribed and the number of days it was used.
The initial January 2003 questionnaire was modified in
April 2004 to collect the following additional data: exact
time interval from exposure to contact with designated
physician.
Statistical Analysis
We analyzed data collected from January 2003 to Decem-
ber 2005. All statistical analyses were performed with the
use of STATA version 9.1 (College Station, TX) and SPSS
(Chicago, version 14.0). Person-time was calculated
assuming that each HCW worked all year round as vaca-
tion time is minimal (<2 weeks per year). In addition,
there were effectively the same number of faculty, house-
staff and nursing staff per year throughout the study
period and approximately the same number of ancillary
hospital staff so we assumed a constant number of 1955
HCW per year. Correlates of high-risk exposure were
examined using chi-square tests for categorical variables
and Mann-Whitney tests for continuous variables. More
detailed information was available on extended PEP from
January 2005 to February 2006 permitting additional
analyses of PEP compliance during this time period. We
also performed logistic regression using time as a linear
variable was performed to assess trends in proportions of
exposures and behavior types over the time period
between 2002 and 2005. Lastly, multivariable logistic
regression was used to identify factors that were inde-
pendently associated with inappropriate prescription of
PEP in cases of low HIV risk exposure. We used the PEP
stat dose exposure variable as the outcome and assessed
age, sex, occupation, department, exposure type, use of
personal protective equipment, visible blood, wound
cleaned stat, source status, year of exposure, and exposure
activity. Factors that were significant in univariable analy-
sis at the p < 0.20 level were considered in the final model.
Results
Characteristics of HCW reporting exposures
Among 1,955 HCW employed between January 2003 and
December 2005, 557 occupational exposures were
reported by 484 HCW. The median age of exposed HCW
was 23 years and 53.2% were male (Table 1). Nearly half
of the reported exposures came from the Medicine and
Obstetrics/Gynecology departments. The greatest number
of exposures was reported among interns (53.1%) (i.e.
persons in their first year post-medical school), followed
by residents (22.8%), who were in years 2 through 5 post-
medical school. Sixty-two HCW reported repeat exposures
during the study period; most were either interns (69.3%)
or residents (19.3%). Overall average annual incidence of
reported exposures among HCW was 9.5 exposures per
100 person-years (PY). Interns had the highest annual
incidence at 47.0/100 PY (Table 2).BMC Infectious Diseases 2008, 8:142 http://www.biomedcentral.com/1471-2334/8/142
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Table 1: Characteristics of 557 HCW reporting occupational exposures at an urban teaching hospital in Pune, India, 2003–2005
Characteristic Total
N = 557 (%)
High-risk#
N = 339 (%)
Low-risk
N = 211 (%)
p
Median Age, years (range) 23 (18–58) 23 (18–58) 23 (18–57) 0.2
Male 295 (53.2) 178 (52.8) 112 (53.1) 0.33
Occupation
Intern 296 (53.1) 159 (46.9) 134 (63.5) 0.0001
Resident 127 (22.8) 84 (24.8) 42 (19.9) 0.19
Nurse 42 (7.5) 28 (8.3) 13 (6.2) 0.36
Student Nurse 33 (5.9) 24 (7.1) 9 (4.3) 0.18
Other 59 (10.6) 38 (11.2) 11 (5.2) 0.02
Department
Medicine 150 (26.9) 101 (29.8) 49 (23.2) 0.09
Obstetrics/Gynecology 132 (23.7) 67 (19.8) 63 (29.9) 0.008
Casualty (emergency room) 96 (17.2) 49 (14.5) 46 (21.8) 0.03
Surgery 84 (15.1) 57 (16.8) 26 (12.3) 0.15
Pediatrics 30 (5.4) 16 (4.7) 14 (6.6) 0.34
Other 58(10.4) 44 (13.0) 11 (5.2) 0.003
Median time between exposure and reporting (n = 329) 
hours:minutes(range)
0:30 (0–122:30) 0:30 (0–122:30) 0:30 (0–23:56) 0.88
Reporting within 24 hours 313 (95.1) 149 (97.3) 164 (100) 0.56
Wound cleaned stat 523 (93.9) 314 (92.6) 203 (96.2) 0.13
Personal protective equipment used 307 (55.1) 182 (53.7) 124 (58.8) 0.25
Gloves 279 (50.1) 165 (48.7) 113 (53.6) 0.26
Mask 52 (9.3) 31 (9.1) 20 (9.5) 0.89
Gown 51 (9.2) 30 (8.8) 20 (9.5) 0.80
Eyewear 18 (3.2) 8 (2.4) 10 (4.7) 0.13
Other 5 (0.9) 5 (1.5) 0 (0.0) 0.54
Hepatitis B Vaccination/job category (% vaccinated) 424 (76.1) 249 (73.5) 172 (81.5) 0.03
Intern 238 (80.4) 125 (78.6) 111 (82.8) 0.0003
Resident 111 (89.5) 72 (85.7) 39 (92.8) 0.43
Student Nurse 22 (66.7) 14 (58.3) 8 (88.9) 0.84
Nurse 26 (61.9) 18 (64.3) 8 (57.1) 0.41
Other 25 (42.4) 19 (50.0) 6 (54.5) 0.13
Exposure characteristic
Percutaneous 452 (81.1) 280 (82.6) 160 (75.8) 0.05
More severe 159 (28.5) 107 (31.6) 49 (23.2) 0.03
Needle stick 420 (75.4) 256 (75.5) 152 (74.1) 0.36
Hollow needle 280 (66.7) 175 (68.4) 105 (69.1) 0.67
Solid needle 111 (26.4) 66 (25.8) 45 (29.6) 0.60
Unknown/not reported 29 (6.9) 15 (5.9) 2 (1.3) 0.02
Laceration 34 (6.1) 24 (7.3) 8 (3.9) 0.11
Mucocutaneous 105 (18.8) 51 (15.4) 45 (22.0) 0.06
Large volume 13 (12.4) 6 (11.8) 4 (9.8) 0.91
Small volume 91 (86.7) 45 (88.2) 41 (91.1) 0.05
Exposed to blood 489 (87.8) 286 (84.4) 200 (94.8) 0.0002
Exposed worker activity
Handling sharp during procedure 331 (59.4) 217 (64.0) 114 (54.0) 0.02
Handling sharp after procedure 98 (17.6) 58 (17.1) 40 (19.0) 0.58
Recapping 46 (8.3) 30 (8.8) 16 (7.6) 0.60
Disposing equipment 30 (5.4) 12 (3.5) 18 (8.5) 0.01
Sharp left around/not safely disposed 31 (5.6) 5 (1.5) 8 (3.8) 0.08
Other 21 (3.8) 8 (2.4) 13 (6.2) 0.02
*Not all percentages add to 100% as some data were missing
#High risk exposure defined as an exposure for which PEP is recommended and includes: (1) cases in which source tested or was known to be HIV 
positive, (2) cases where source was judged to be at high risk for HIV by clinicians, and (3) cases where source status and/or risk for HIV remained 
unknown.BMC Infectious Diseases 2008, 8:142 http://www.biomedcentral.com/1471-2334/8/142
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Ninety-five percent of HCW reported their exposure
within 24 hours; the median time between exposure and
reporting was 30 minutes. Fifty-five percent of HCW
reported using PPE at the time of their exposure. Gloves
were used in 50.1% of all exposures, while 9.3% reported
use of a mask. Baseline Hepatitis B vaccination rate was
79.1%. Housestaff were more likely to have been vacci-
nated than others (82.5% vs. 54.5%, p < 0.0001).
Exposure Description
Of 557 exposures, 452 (81.1%) exposures were percuta-
neous (75.1% were needlesticks and 6.1% were lacera-
tions) and 105 (18.8%) were mucocutaneous (Table 1). A
total of 429 (77.0%) of exposures were due to handling a
sharp during or after a procedure; recapping specifically
accounted for 46 (8.3%) of exposures. Percutaneous
exposures were the most common across all job categories
except for nurses for whom mucocutaneous exposures
were more common (Table 2).
High-risk exposures
The incidence of high-risk exposures (PEP recommended
according to CDC guidelines) was 6.8/100 PY. A majority
(83.8%) of exposures were percutaneous and 49.2% inci-
dents occurred during a procedure or disposing of equip-
ment. Interns and residents made up 46.9% and 24.8% of
these exposures, respectively.
Source Description
The overall HIV prevalence of known source patients was
15.8%. Source status was known prior to exposure in 101
(18.1%) cases, 73 (72.3%) of whom were HIV-infected.
For 456 cases where source status was unknown prior to
testing, the clinicians judged 75 (13.4%) sources to be
high risk for HIV. Seven (9.3%) of these 75 tested HIV-
positive compared to 5 (2.6%) of 188 cases judged to be
at low risk for HIV and 3 (15%) of 20 determined to be
unknown risk (p = 0.02).
As a result of HIV testing, 15 additional sources were iden-
tified as HIV-positive, with rapid HIV antibody testing
capturing 13 cases. Although ELISA was recommended for
all sources whose status was unknown prior to testing,
only 26 (5.7%) had them performed. In contrast, 320
(57.5%) source patients had rapid HIV antibody tests
completed. The source status remained unknown for 173
(31.1%) of exposures.
Exposure Management and PEP utilization
A stat PEP dose was given for 401 (72.0%) exposures; 265
(80.0%) of 339 high-risk exposures and 136 (62.4%) of
218 other exposures (Figure 1). For 72 (81.8%) of 88
exposures where the source was determined to be HIV-
infected, the HCW received a stat dose.
Excluding sources that ultimately tested HIV-negative in
the high-risk exposures, 217 (64.0%) cases warranted
extended PEP regimen based on CDC guidelines. When
the source status was confirmed to be HIV-positive, 58
(65.9%) HCW began and 34 (58.6%) completed more
than 20 days of a PEP regimen. In 129 high-risk cases
where source status remained unknown, 47 (36.4%) ini-
tiated extended PEP, 18 (38.3%) completed more than 20
days, and 11 (23.4%) stopped due to intolerance to PEP
regimen. PEP extended regimen was begun on 20 (16.1%)
cases where the source was confirmed to be HIV-negative,
and in 7 (35.0%) the regimen was taken for 20 or more
days.
Tetanus vaccination was administered to 113 persons
who could not recall tetanus vaccination or had not had it
in the past 5 years and Hepatitis B vaccine was given to 67
of 112 persons who had not previously received it. Ten
HCW received Hepatitis B immune globulin because they
were considered to have a high risk exposure to Hepatitis
B. There were no documented or reported HIV or Hepati-
tis B seroconversions during the study period.
Table 2: Average incidence of exposures by job category per 100 person-years (PY) at an urban teaching hospital in Pune, India 2003–
2005.
Job category Number employed* Total exposures per 
100 PY
Percutaneous 
exposures per 100 
PY
Mucocutaneous 
exposures per 100 
PY
High-risk exposure 
per 100 PY**
Interns 210 47.0 38.9 8.1 25.2
Residents 300 14.1 10.8 3.3 9.3
Student Nurses 120 9.4 6.1 3.1 6.7
Nurses 703 2.0 0.3 1.7 1.3
Other 622 3.1 2.8 0.4 2.0
Total 1955 9.5 7.7 1.8 6.8
*Number of employees per year in each job category was assumed to have remained stable over the 3-year period.
**High risk exposure defined as an exposure fro which PEP is recommended according to US CDC guidelines (1) and includes: (1) cases in which 
source tested or was known to be HIV positive, (2) cases where source was judged to be at high risk for HIV by clinicians, and (3) cases where 
source status and/or risk for HIV remained unknown.BMC Infectious Diseases 2008, 8:142 http://www.biomedcentral.com/1471-2334/8/142
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Factors associated with PEP initiation in context of low risk 
HIV exposures
Of 557 exposures, 218 were defined as low risk HIV expo-
sures based on CDC guidelines and 136 (24.4%) of these
received a stat PEP dose. The factors independently asso-
ciated with receiving stat PEP despite having a low risk
HIV exposure were type of exposure other than needle-
stick (e.g. splash) [adjusted odds ratio (AOR) 2.9, 95% CI
1.1–7.9], source HIV status unknown (AOR 6.1, 95% CI
2.5–15.0), exposure occurred when sharp was left around
or in trash (AOR 4.4, 95% CI 1.9–9.9), or blood was visi-
ble (AOR 1.9, 95% CI 1.1–3.6).
Trends over time
Over a 3-year period, percutaneous exposures decreased
significantly over time (p = 0.002) as did high-risk expo-
sures (p < 0.001) (Figure 2A). Mucocutaneous exposures,
however, increased over time (p = 0.002). The proportion
of sources known HIV-positive prior to testing did not
change significantly over time, nor did use of PPE or hep-
atitis B vaccination change over time (p > 0.05).
Overall the utilization of PEP stat doses did not increase
over time but recommended use of PEP stat doses for high
risk exposures did increase significantly over time (44% in
PEP extended regimen use: Clinical decisions and HCW compliance Figure 1
PEP extended regimen use: Clinical decisions and HCW compliance. *High risk exposure defined as an exposure for 
which PEP is recommended according to US CDC guidelines (1) and includes: 1) cases in which source tested or was known to 
be HIV positive, 2) cases where source was judged to be at high risk for HIV by clinicians, and 3) cases where source status 
and/or risk for HIV remained unknown.
Source HIV positive  
 
88 (40.0) 
Used 20 days or 
more 
 34 (58.6) 
High risk exposures* 
339 (60.9)
PEP stat dose given
265 (80.0) 
Source high risk for HIV or 
unknown source  
129 (60.0)
Extended PEP 
begun 
47 (36.4)
Used 20 days or 
more 
18 (38.3)
Extended PEP 
begun 
58 (65.9) 
Source tested HIV 
negative 
122 (40.0) 
Extended PEP 
warranted 
217 (60.0) 
Total Exposures 
557  BMC Infectious Diseases 2008, 8:142 http://www.biomedcentral.com/1471-2334/8/142
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2003 to 100% in 2005, p = 0.002) (Figure 2B). The odds
of receiving extended PEP regimen for high-risk exposures
increased significantly over time (OR 1.24; 95% CI 1.09–
1.42; p = 0.001).
Discussion
Our prospective study at a large public teaching hospital
in India highlights the high incidence of occupational
exposures, particularly among medical housestaff. We
found that only half of the exposures involved use of PPE.
While recapping contributed to exposures, handling
sharps such as IV needles and sutures during a procedure
or after a procedure were the most common reason for an
exposure. Hepatitis B vaccination, which was highest
among medical housestaff and lowest among ancillary
hospital staff, nevertheless was higher than that reported
in many other resource-constrained settings [15-17]. In
the setting of HCW education and a structured PEP pro-
gram, the reported number of percutaneous and high risk
exposures decreased over time and the utilization and
appropriate implementation of PEP increased over time.
Only a few studies have been published regarding occupa-
tional exposures in India. A study at a private non-teach-
ing hospital in Mumbai found that over a six-year period,
380 needlestick injuries were reported [18]. Nurses
reported the greatest number of exposures with IV line
insertion being the most common activity during expo-
sure. In a cross-sectional survey of 266 HCW in rural north
India working in non-governmental health settings of 115
beds or less, nurses again had the highest reported
number of exposures in the past year [12]. In our study,
intern doctors (in their first year of training post-medical
school) reported the highest incidence of first-time and
repeat exposures. Several reasons may underlie interns
high rates of exposure. Our study was in a teaching hospi-
tal where interns not nurses or other hospital personnel
are expected to do routine blood draws, suturing and IV
insertion procedures. Paired with their inexperience, long
work hours and high volume of inpatient procedures puts
interns at high risk. Other teaching hospitals have also
reported the highest incidence of exposures among hous-
estaff in both resource-contrained and resource-rich set-
tings [19-22]. In South Africa, a survey of 98 interns found
that 69% had one or more percutaneous exposures to
blood, and similar to our study, these commonly occurred
because of unexpected patient movement during proce-
dures or during disposal of needles [20]. Data from a large
study of US residents found that extended work duration
and night work among interns is associated with increased
risk of percutaneous injuries [19].
There are few studies regarding incidence of occupational
exposures or PEP utilization in resource-contrained set-
tings. A cross-sectional survey of Nigerian HCW at a teach-
ing hospital found that 27% of HCWs had a needlestick in
the past year with a rate of 0.6/PY [15]. The majority were
dentists (100%) and surgeons (81%), followed by other
physicians (31%), and nursing staff (31%). They reported
patient movement, recapping, and accidental stick by col-
league to be the major reasons for HCW exposure. A
recent survey of HCW in Kenya found that there was low
uptake of PEP (4% of needlestick injuries), and this was
largely attributed to HCW fear of getting HIV tested as well
as the perception that needlestick exposures were low risk
for HIV [23]. In a small study in Malawi, PEP was report-
edly underutilized with 19 of 29 HCW initiating PEP [24].
Many of these HCW were nurses and one of the reasons
for low use of PEP was lack of awareness and fear of get-
ting HIV tested.
Given that so many high-risk exposures occurred during
or after a procedure, it is likely that improved use of PPE
and introduction of safer medical devices (e.g. needleless
systems and sharps with engineered sharps-injury protec-
tions) would reduce the occurrence of high risk exposure
to contaminated sharps. A review of published studies has
shown that these safer devices are associated with a reduc-
tion in percutaneous injury rates of 22–100% [25]. One of
the major limitations to use of these devices is the cost.
Efforts to reduce their cost by having local manufacturers
produce them and having legislation to motivate demand
for the use of these products is needed.
For the vast majority of cases, a stat PEP dose was admin-
istered within 24 hours suggesting quick assessment and
good access to PEP was possible in our setting. Similar to
other studies, we found rapid tests for HIV were more con-
venient and useful than ELISA-based testing for determin-
ing source status [26,27]. However, we did determine that
PEP overuse was apparent for exposures judged to be low
risk or the source was known to be HIV-negative. Only
66.1% of cases that received stat doses met CDC guide-
lines for which PEP is recommended. Furthermore,
extended PEP regimens were used in 20 exposure cases
even though the source tested HIV-negative. Designated
clinicians indicated that one reason for the over-prescrip-
tion of PEP stat doses and regimens was worker anxiety
and misconceptions about the threat of HIV despite coun-
seling by the on-call PEP physician. However, in the initial
few weeks post-exposure many reviewed the indications
for PEP and risk of HIV from available books and the
internet and many subsequently realized that PEP was not
indicated in them and hence discontinued. This was par-
ticularly true about the residents in Medicine, Obstetrics/
Gynecology and Pathology. During the study, however,
we observed that appropriate PEP utilization improved
over time suggesting that there had been improved knowl-
edge in the hospital setting regarding the true risk of
bloodborne infection due to occupational exposure. Nev-BMC Infectious Diseases 2008, 8:142 http://www.biomedcentral.com/1471-2334/8/142
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A. Trends over time in exposure types in a large teaching hospital in Pune, India, 2003–2005 Figure 2
A. Trends over time in exposure types in a large teaching hospital in Pune, India, 2003–2005. B. Trends over time 
in PEP stat dose and extended regimen utilization types in a large teaching hospital in Pune, India, 2003–2005. *High risk expo-
sure defined as an exposure fro which PEP is recommended according to US CDC guidelines (1) and includes: (1) cases in 
which source tested or was known to be HIV positive, (2) cases where source was judged to be at high risk for HIV by clini-
cians, and (3) cases where source status and/or risk for HIV remained unknown.BMC Infectious Diseases 2008, 8:142 http://www.biomedcentral.com/1471-2334/8/142
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ertheless, continued education about the true risk for HIV
infection from exposures and guidelines for PEP use are
needed to reduce HCW anxiety and optimize PEP utiliza-
tion.
PEP coverage and compliance with an extended regimen
in our study were similar to what has been reported in the
US by the CDC [1]. Data from US National Surveillance
System for Hospital Health Care Workers found that 6%
of exposures were from HIV-infected sources and 63% of
these HCW started PEP, with 54% taking it for 20 days or
more[1]. In our study a higher proportion (15.7%) of
exposures were from known HIV-infected sources. How-
ever, similar to US data, 65.9% of these cases began an
extended PEP regimen, with 58.6% taking PEP for 20 days
or more. Early discontinuation of extended PEP was often
due toGI side effects of AZT. Ward attendants andsweep-
ers more often discontinued PEP than interns or residents.
While we do not have the exact reasons for this; we sur-
mise it is likely because they did not perceive themselves
to be at high risk for HIV infection and they were also less
likely to truly have high risk exposures. They also may
have been less knowledgeable about importance of adher-
ence to PEP and may have experienced side effects of the
PEP medications. It is important to note that indinavir
was commonly used in the PEP combination. This drug
was among the first PIs developed and used in early PEP
regimens in the US but now is very rarely used as more tol-
erable and potent PIs are available and are recommended.
Since our incidence rates were based on reported inci-
dents, it is likely that the rates are underestimated as sev-
eral studies have found that many exposures are not
reported. It is also possible that housestaff may have been
more likely to be aware of the PEP program and more
likely to report an exposure than other hospital staff but
we would still expect that because housestaff are the most
likely to perform procedures at a teaching hospital that
they would have the highest exposure rates. Follow-up
was inadequate and likely reflects the difficulty of relying
on housestaff to return for follow-up visits on their own
initiative. It is therefore possible there may have been
some undetected HIV or Hep B seroconversions. A proto-
col for more active follow-up has been subsequently put
into place. Another limitation was that our study took
place at one large public teaching hospital and may not be
generalizable to other hospital settings in India, where a
formal program for reporting occupational exposures and
providing PEP may be lacking.
Conclusion
Our study suggests that a comprehensive program cover-
ing universal precautions, procedural training and sharps
handling is imperative for HCW, in particular for interns
at teaching hospitals. With their high exposure rates in
mind, interns would likely benefit from greater supervi-
sion during procedures. Improved use of PPE, access to
reliable rapid HIV testing, introduction of safer medical
devices for procedures, and continued education regard-
ing appropriate use of PEP are necessary to ensure optimal
HCW safety in resource-limited settings such as India.
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